Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837512 · ClinicalTrials.gov registry record · Phase 2
Insulin Delivery Using Microneedles in Type 1 Diabetes
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00837512 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 16 participants.
The verdict
NCT00837512, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this study is to determine if microneedles can effectively and painlessly deliver insulin to children and young adults with type 1 diabetes.
Interventions
- DEVICE Microneedle
- DEVICE Subcutaneous insulin catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00837512
The ClinicalTrials.gov registry entry for NCT00837512 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Microneedle is the first listed.
NCT00837512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00837512 about?
NCT00837512 is a clinical study titled "Insulin Delivery Using Microneedles in Type 1 Diabetes". The goal of this study is to determine if microneedles can effectively and painlessly deliver insulin to children and young adults with type 1 diabetes.
What is the current status of trial NCT00837512?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2008-09. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00837512?
The interventions under investigation include: Microneedle (DEVICE), Subcutaneous insulin catheter (DEVICE).
Who is sponsoring clinical trial NCT00837512?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.